CYP4B1 and adrenal gland cancer: The prognosis of LUAD, CESC and KIRC patients with low expression of CYP4B1 is poor, which is consistent with the findings of urethral cancer and adrenal cancer (Genter et al., 2006; Murtha et al., 2017; Lin et al., 2019).